Just some weekend fancy guys and girls.....remember those old Star Trek episodes (from the very beginning) where diagnosis was done by machine?
this is now happening......and ResApp is one of the front runners......not only does the accuracy need to be exact....but also the social acceptance.
Given the slow progress of machine capability on the general public over the last two decades, there is gradual acceptance that this is better than a GP, so the social acceptance is probably an 'easy' fix.
What ResApp have done, and are doing, is to provide a basic highly accurate tool. And they have chosen the RIGHT TOOL AT THE RIGHT TIME....ie respiratory issues, in the health sector this is probably low hanging fruit, but at the ground floor, to get it right opens up a massive disruption to world health.
Good luck all those that are in..........as for t/o discussions - am concerned about FIL accumulating so much in so short a time.....but then again, good luck to FIL........they have seen it..others have now.
Ports - as said before will not be letting anything go under $42
and still accumulating.....go where the smart money is guys and girls, FIL are not dummies!
- Forums
- ASX - By Stock
- RAP
- RAP - The Main Game
RAP - The Main Game, page-1134
-
-
- There are more pages in this discussion • 471 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online